NCT02936102 2025-11-14A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.NovartisPhase 1 Terminated154 enrolled
NCT05355753 2024-12-17A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null TumorsC4 Therapeutics, Inc.Phase 1 Terminated49 enrolled